Back to mobile site

Leerink Swann Downgrades Genomic Health (GHDX) to Market Perform

January 17, 2008 9:24 AM EST Send to a Friend
Leerink Swann downgrades Genomic Health (Nasdaq: GHDX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login